CA2116862A1 - Formulations medicinales en aerosol - Google Patents

Formulations medicinales en aerosol

Info

Publication number
CA2116862A1
CA2116862A1 CA 2116862 CA2116862A CA2116862A1 CA 2116862 A1 CA2116862 A1 CA 2116862A1 CA 2116862 CA2116862 CA 2116862 CA 2116862 A CA2116862 A CA 2116862A CA 2116862 A1 CA2116862 A1 CA 2116862A1
Authority
CA
Canada
Prior art keywords
formulation
drug
propellant
glycerol phosphatide
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2116862
Other languages
English (en)
Inventor
Martin J. Oliver
Philip A. Jinks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2116862A1 publication Critical patent/CA2116862A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA 2116862 1991-09-03 1992-08-28 Formulations medicinales en aerosol Abandoned CA2116862A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919118830A GB9118830D0 (en) 1991-09-03 1991-09-03 Medical aerosol formulations
GB91.18830.0 1991-09-03

Publications (1)

Publication Number Publication Date
CA2116862A1 true CA2116862A1 (fr) 1993-03-18

Family

ID=10700844

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2116862 Abandoned CA2116862A1 (fr) 1991-09-03 1992-08-28 Formulations medicinales en aerosol

Country Status (5)

Country Link
EP (1) EP0602181A1 (fr)
AU (1) AU2573892A (fr)
CA (1) CA2116862A1 (fr)
GB (1) GB9118830D0 (fr)
WO (1) WO1993004671A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
AU4894697A (en) 1997-10-01 1999-04-23 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US6660715B2 (en) * 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
DE19911064A1 (de) * 1999-03-12 2000-09-14 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
DE10260882B4 (de) * 2002-12-24 2007-02-08 IG Sprühtechnik GmbH & Co. KG Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung
NZ523920A (en) 2003-01-31 2005-11-25 Fonterra Co Operative Group Methods for extracting lipids from diary products using a near critical phase fluid
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
KR101619077B1 (ko) * 2010-06-11 2016-05-10 레오 파마 에이/에스 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (fr) * 1962-05-24
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB9001019D0 (en) * 1990-01-17 1990-03-14 Euro Celtique Sa Pharmaceutical aerosol
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen

Also Published As

Publication number Publication date
WO1993004671A1 (fr) 1993-03-18
AU2573892A (en) 1993-04-05
GB9118830D0 (en) 1991-10-16
EP0602181A1 (fr) 1994-06-22

Similar Documents

Publication Publication Date Title
DK175346B1 (da) Lægemiddelholdigt chlorfluorcarbon-aerosol-præparat, fremgangsmåder til solubilisering af et lægemiddel samt aerosolpakninger fyldt med præparatet
JP2786493B2 (ja) 医薬エアゾール製剤
CA2116862A1 (fr) Formulations medicinales en aerosol
US5439670A (en) Medicinal aerosol formulations
US5720940A (en) Medicinal aerosol formulations
US6352684B1 (en) CRC-free medicinal aerosol formulations of 1,1,1,2-tetrafluoroethane (134A) with polar adjuvant
KR100375469B1 (ko) 약제
CA2338753C (fr) Formulations pour aerosols a usage medical
EP0556256B1 (fr) Medicaments en aerosol
EP1306082B1 (fr) Aérosols doseurs sous pression et compositions pharmaceutiques d'aérosol
CZ288146B6 (en) Pharmaceutical aerosol preparation, process of its preparation and use
HU211696A9 (en) Medicaments
ITMI982558A1 (it) Formulazioni di aerosol medicinali
EP0553298A1 (fr) Formulation d'aerosol contenant du beclomethasone 17,21 dipropionate.
JPH07509475A (ja) 医薬
KR0175164B1 (ko) 에어로졸 약물 제제
NZ243056A (en) Aerosol formulation containing a medicament, tetrafluoroethane and isopropyl myristate
CA2303601A1 (fr) Aerosols medicinaux
WO1998007419A1 (fr) Aerosol pour le traitement de l'asthme

Legal Events

Date Code Title Description
FZDE Dead